Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Biomerieux 69 Marcy L'Etoile (OTC: BMXMF).

Full DD Report for BMXMF

You must become a subscriber to view this report.


Recent News from (OTC: BMXMF)

T2 Biosystems Might Hit A Home Run In 2018
T2 Biosystems ( TTOO ) is a small in vitro diagnostics company that has developed a technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies. The company's T2 Magnetic Resonance technology (T2MR) aims to lower mortality rates, improve...
Source: SeekingAlpha
Date: February, 26 2018 19:36
Biomerieux 69 Marcy L'Etoile reports 1H results
Biomerieux 69 Marcy L'Etoile ( OTCPK:BMXMF ): 1H EPS of €2.17 Revenue of €1B (+7.2% Y/Y) Press Release More news on: Biomerieux 69 Marcy L'Etoile, Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: August, 31 2016 04:57
Biomerieux 69 Marcy L'Etoile reports Q2 results
Biomerieux 69 Marcy L'Etoile ( OTCPK:BMXMF ): Q2 Revenue of €512.3M (+5.6% Y/Y) More news on: Biomerieux 69 Marcy L'Etoile, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: July, 18 2016 08:13
Avant Diagnostics (AVDX) Announces a Partnership of Promise with Amarantus Diagnostics
The recent announcement by Avant Diagnostics, Inc (OTCQB: AVDX) and Amarantus Bioscience Holdings, Inc (OTCQX: AMBS) of their intention to tie the knot is a message of cheer for women who may be at risk for ovarian cancer. It also promises a partnership that will aggressively pursue opportun...
Source: DreamTeamNetwork
Date: February, 18 2016 09:30
Spin-out from bioMerieux secures $32M capital raise
BioTheranostics , a spin-out from French diagnostics firm bioMerieux ( OTCPK:BMXMF ) closes $32M in financing from institutional investors that will fund its operations as an independent entity. The company offers a suite of molecular diagnostic tests that allow treatment to be customize...
Source: SeekingAlpha
Date: January, 21 2016 10:23
BioMerieux Q2 sales up 18%; sees 2015 top-line growth of 4.5 - 6.5%
French diagnostics firm bioMerieux ( OTCPK:BMXMF ) Q2 results (M): Total Revenue: 479.6 (+18.3%); Europe: 210.9 (+1.2%); Americas: 181.8 (+39.6%); Latin America: 34.8 (+6.1%); Asia-Pacific: 86.9 (+29.9%). More news on: Biomerieux 69 Marcy L'Etoile, Healthcare stocks news, Earnings news a...
Source: SeekingAlpha
Date: July, 17 2015 07:29

 


About Biomerieux 69 Marcy L'Etoile (OTC: BMXMF)

Logo for Biomerieux 69 Marcy L'Etoile (OTC: BMXMF)

Biomerieux SA designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring instruments, platforms, or autoanalyzers used for automated testing at high or low throughputs software to process analyses and systems to interpret the biological test results and related services, such as the installation and maintenance of instruments, user training, or the audit of laboratory workflows. It offers diagnostic systems for clinical applications, including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples, such as blood, saliva, and urine and for industrial applications, including the analysis of microbiological manufacturing, such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories food, pharmaceutical, and cosmetics industries and independent quality control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia Pacific, and Latin America. The company was founded in and is headquartered in Marcy l Etoile, France.

 

 

 

Current Share Structure

     



    Daily Technical Chart for (OTC: BMXMF)

    Daily Technical Chart for (OTC: BMXMF)


    Stay tuned for daily updates and more on (OTC: BMXMF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: BMXMF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    OTC Report
    @OTCReporter

     

     


    Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BMXMF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of BMXMF and does not buy, sell, or trade any shares of BMXMF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/